Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600117273Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in Cardiac valve disease (VHD) (2 arms), sponsored by Meishan Municipal People's Hospital. Primary endpoints: Post-induction hypotension (PIH) and Total dose of norepinephrine used. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600117273.